Clinical Trials
Web
Site
Search
Saturday, July 05, 2008
..::
Clinical Trials
::..
Register
Login
Clinical Trials
View All Recent Entries
All Programs
BMT
Breast
Cutaneous
Gastrointestinal
Genitourinary
Gynecologic Oncology
Head & Neck
Malignant Hematology
Neuro-Oncology
Pediatric
Sarcoma
Thoracic
Search Trials
All
All Programs
BMT
Breast
Cutaneous
Gastrointestinal
Genitourinary
Gynecologic Oncology
Head & Neck
Malignant Hematology
Neuro-Oncology
Pediatric
Sarcoma
Thoracic
Keywords
Phrase
Archives
Study Number:
Search
Genitourinary
Category:
Genitourinary
Created:
1/2/2007 11:31 AM
Genitourinary
Bladder (100892)
Sponsor: Genentech (AVF 3312)
By Genitourinary on
7/5/2008 10:00 AM
A Phase II Study of Neo-adjuvant Cisplatin, Gemcitabine, & Avastin, followed by Radical Cystectomy for Patients with Muscle invasive, Resectable, Non-Metastatic Transitional Cell carcinoma (TCC) of the Bladder
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Bladder (101108)
Sponsor: RTOG (0524)
By Genitourinary on
7/5/2008 10:00 AM
A Phase I/Ii Trial Of A Combination Of Paclitaxel And Trastuzumab With Daily Irradiation Or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery For Non -Cystectomy Candidates With Muscle-Invasive Bladder Cancer
HIPAA Authorization
Informed Consent
Protocol
More...
Kidney (101026)
Sponsor: CTSU/ECOG (E2805)
By Genitourinary on
7/5/2008 10:00 AM
A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib Vs Sorafenib Vs Placebo in Patients with Resected Renal Cell Carcinoma
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Kidney (101102)
Sponsor: ZymoGenetics (494F01)
By Genitourinary on
7/5/2008 10:00 AM
A Phase 1/2, Open-Label, Dose Escalation Study to Assess the Safety and Pharmacokinetics of Recombinant Interleukin 21 (rIL-21) Administered Concomitantly with Sorafenib (Nexavar) in Subjects with Metastatic Renal Cell Carcinoma
HIPAA Authorization
Informed Consent
Protocol
More...
Kidney (101117)
Sponsor: Amgen, Inc. (20060159)
By Genitourinary on
7/5/2008 10:00 AM
A Randomized, Double Blinded, Multi-Center Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Sorafenib in Combination with AMG 386 or Placebo as First Line Therapy for Subjects with Metastatic Clear Cell Carcinoma of the Kidney
HIPAA Authorization
HIPAA Authorization
HIPAA Authorization
Informed Consent
Informed Consent
More...
Kidney (101117)
Sponsor: Amgen, Inc. (20060159)
By Genitourinary on
7/5/2008 10:00 AM
A Randomized, Double Blinded, Multi-Center Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Sorafenib in Combination with AMG 386 or Placebo as First Line Therapy for Subjects with Metastatic Clear Cell Carcinoma of the Kidney
HIPAA Authorization
HIPAA Authorization
HIPAA Authorization
Informed Consent
Informed Consent
More...
Kidney (101143)
Sponsor: Abbott Laboratories (M06-882)
By Genitourinary on
7/5/2008 10:00 AM
An Open Label, Phase 2 Study to Evaluate the Efficacy and Tolerability of ABT-869 in Subject with Advanced Renal Cell Carcinoma (RCC) Who Have Previously Received Treatment With Sunitinib.
None Available
More...
Prostate (100783)
Sponsor: MUSC (100783)
By Genitourinary on
7/5/2008 10:00 AM
PHASE I TRIAL OF CONCURRENT TAXOTERE WITH RADIATION THERAPY AND HORMONAL THERAPY FOR CLINICALLY LOCALIZED HIGH RISK PROSTATE CANCER
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Prostate (100822)
Sponsor: Millennium (03-1218)
By Genitourinary on
7/5/2008 10:00 AM
VELCADE (bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Prostate (101121)
Sponsor: Cancer Treatment Research Foundation (101121)
By Genitourinary on
7/5/2008 10:00 AM
A Study of Vitamin D in Prostate Cancer
None Available
More...
Prostate (101137)
Sponsor: Unviersity of CA-Irvine (CA180-0097)
By Genitourinary on
7/5/2008 10:00 AM
A Phase II Trial Of Dasatinib(Sprycel®) In Subjects With Hormonerefractory Prostate Cancer, Previously Treated With Chemotherapy
HIPAA Authorization
Informed Consent
Protocol
More...
Prostate (101217)
Sponsor: RTOG (0534)
By Genitourinary on
7/5/2008 10:00 AM
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (Sport) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy
HIPAA Authorization
HIPAA Authorization - VA
Informed Consent
Informed Consent - VA
Protocol
Protocol
More...
Copyright 2007 by Hollings Cancer Center
Terms Of Use
Privacy Statement